ArticleNeuro-oncology2022

DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients.

Franz L Ricklefs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.